 Survival Rate
"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 0 | 8 | 8 | | 1991 | 0 | 11 | 11 | | 1992 | 0 | 8 | 8 | | 1993 | 0 | 19 | 19 | | 1994 | 0 | 18 | 18 | | 1995 | 0 | 12 | 12 | | 1996 | 0 | 8 | 8 | | 1997 | 0 | 24 | 24 | | 1998 | 0 | 20 | 20 | | 1999 | 0 | 16 | 16 | | 2000 | 0 | 24 | 24 | | 2001 | 0 | 26 | 26 | | 2002 | 0 | 26 | 26 | | 2003 | 1 | 24 | 25 | | 2004 | 0 | 25 | 25 | | 2005 | 0 | 35 | 35 | | 2006 | 0 | 47 | 47 | | 2007 | 0 | 43 | 43 | | 2008 | 0 | 53 | 53 | | 2009 | 0 | 54 | 54 | | 2010 | 1 | 63 | 64 | | 2011 | 0 | 71 | 71 | | 2012 | 1 | 52 | 53 | | 2013 | 0 | 67 | 67 | | 2014 | 1 | 82 | 83 | | 2015 | 0 | 68 | 68 | | 2016 | 1 | 64 | 65 | | 2017 | 0 | 84 | 84 | | 2018 | 0 | 40 | 40 | | 2019 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Moreira DC, Macy ME, Cost CR, Greffe BS, Garrington TP. Central Nervous System Involvement of Rhabdomyosarcoma: A Single Institution Experience. J Pediatr Hematol Oncol. 2019 03; 41(2):152-154.
-
Bardia A, Mayer IA, Vahdat LT, Tolaney SM, Isakoff SJ, Diamond JR, O'Shaughnessy J, Moroose RL, Santin AD, Abramson VG, Shah NC, Rugo HS, Goldenberg DM, Sweidan AM, Iannone R, Washkowitz S, Sharkey RM, Wegener WA, Kalinsky K. Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer. N Engl J Med. 2019 02 21; 380(8):741-751.
-
Foster CC, Sher DJ, Rusthoven CG, Verma V, Spiotto MT, Weichselbaum RR, Koshy M. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis. Radiat Oncol. 2019 Jan 28; 14(1):18.
-
Cortes JE, Heidel FH, Hellmann A, Fiedler W, Smith BD, Robak T, Montesinos P, Pollyea DA, DesJardins P, Ottmann O, Ma WW, Shaik MN, Laird AD, Zeremski M, O'Connell A, Chan G, Heuser M. Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome. Leukemia. 2019 02; 33(2):379-389.
-
Mira-Avendano I, Abril A, Burger CD, Dellaripa PF, Fischer A, Gotway MB, Lee AS, Lee JS, Matteson EL, Yi ES, Ryu JH. Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases. Mayo Clin Proc. 2019 02; 94(2):309-325.
-
Jacobs L, Berrens Z, Stenson EK, Zackoff M, Danziger-Isakov L, Lahni P, Wong HR. Interleukin-27 as a candidate diagnostic biomarker for bacterial infection in immunocompromised pediatric patients. PLoS One. 2018; 13(11):e0207620.
-
Ikeno Y, Miyahara S, Koda Y, Yokawa K, Gotake Y, Henmi S, Nakai H, Matsueda T, Inoue T, Tanaka H, Okita Y. Early and long-term outcomes of open surgery after thoracic endovascular aortic repair. Interact Cardiovasc Thorac Surg. 2018 10 01; 27(4):574-580.
-
Taylor VA, Kirby CL, Nehus EJ, Goebel J, Hooper DK. Composite Health Outcomes in Pediatric and Young Adult Kidney Transplant Recipients. J Pediatr. 2019 01; 204:196-202.
-
Bhatt J, Prager JD. Neonatal Stridor: Diagnosis and Management. Clin Perinatol. 2018 12; 45(4):817-831.
-
Newman EA, Abdessalam S, Aldrink JH, Austin M, Heaton TE, Bruny J, Ehrlich P, Dasgupta R, Baertschiger RM, Lautz TB, Rhee DS, Langham MR, Malek MM, Meyers RL, Nathan JD, Weil BR, Polites S, Madonna MB. Update on neuroblastoma. J Pediatr Surg. 2019 Mar; 54(3):383-389.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|